Skip to main content
. 2019 Jul 13;20(14):3446. doi: 10.3390/ijms20143446

Figure 2.

Figure 2

A smoker 43-year-old male patient classified as Androgenic alopecia (AGA) 4 according to the Norwood–Hamilton Scale, in baseline and after Human Intra and Extra Dermal Adipose Tissue-Derived Hair Follicle Stem Cells (HD-AFSCs) treatment. (A) Timing T0 (before the treatment) with hair loss localized to the vertex, parietal, temporal, and frontal areas, (B) Timing at T5, 44 weeks after the last micro-grafts injection with an increase of hair density in the targeted area. White arrow indicates the demarcated point in which the histological analysis and Trichoscan evaluation were performed.